Solutions
About Us
Insights
Careers
Contact us
Contact Us
Customer Support
Customer Support

Webinar – AI in HEOR: Case Studies on Navigating Regulatory and HTA Guidance

Intersectoral action to transform health equity for women and girls globally. Sarri, G., Soriano Gabarró, M. S., Cheng, R. F., & Jhutti-Johal, J. (2025). Communications medicine, 6(1), 40.

Patient characteristics, burden of disease, healthcare resource utilization and costs in acute myeloid leukemia – a retrospective observational study with German claims data. Greth, K., Lehne, M., Ghiani, M., Mevius, A., Purcell, S., Kaulfuss, S., Gokhale, M., & Russell, A. (2026). Journal of comparative effectiveness research, 15(1), e240196.

Webinar – Leveraging the Right Advanced Quantitative Methods to Address Evidentiary Gaps

White Paper – Randomized Controlled Trials Aren’t Enough Why Comparative Effectiveness is the New Strategic Imperative

Webinar – The Role of Real-World Evidence in Addressing Post-Launch Needs

Long-term risk of HCC in a DAA-treated national hepatitis C cohort, and a proposed risk score. Lybeck C, Bruce D, Szulkin R, Montgomery S, Aleman S, Duberg AS. Infect Dis (Lond).

Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. Sutton AJ, Lupu DS, Bergin SP, Holland TL, McAdams SA, Dadwal SS, Nguyen K, Nolte FS, Tremblay G, Perkins BA. Pharmacoeconomics. 2024

The maze of real-world evidence frameworks: from a desert to a jungle! An environmental scan and comparison across regulatory and health technology assessment agencies. Sarri G, Hernandez LG. J Comp Eff Res. 2024

A Systematic Review of Modeling Approaches to Evaluate Treatments for Relapsed Refractory Multiple Myeloma: Critical Review and Considerations for Future Health Economic Models. Freitag A, Sarri G, Ta A, Gurskyte L, Cherepanov D, Hernandez LG. Pharmacoeconomics. 2024